BIOLIFE SOLUTIONS INC (BLFS:NASDAQ)
$37.22 0.03 (0.0807%)
Analysed BIOLIFE SOLUTIONS INC (BLFS:NASDAQ) News Sources
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
22-07-2026
marketbeat.com
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout
23-07-2026
yahoo.com
Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance
28-07-2026
advfn.com
BioLife Solutions Reports Second Quarter 2026 Financial Results
06-08-2026
yahoo.com
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Surpass Estimates
06-08-2026
yahoo.com
Repligen (RGEN) Held An M&A Call With BioLife Solutions.
28-07-2026
yahoo.com
BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair Value
04-06-2026
yahoo.com
What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?
18-06-2026
yahoo.com
Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
22-07-2026
yahoo.com
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 Profit - What's Changed
07-08-2026
yahoo.com
What is the current price of BIOLIFE SOLUTIONS INC (BLFS:NASDAQ)?
The current price of BIOLIFE SOLUTIONS INC (BLFS:NASDAQ) is $37.22.
BIOLIFE SOLUTIONS INC (BLFS:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOLIFE SOLUTIONS INC (BLFS:NASDAQ) since the previous trading day is $0.03.
BIOLIFE SOLUTIONS INC (BLFS:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOLIFE SOLUTIONS INC (BLFS:NASDAQ) since the previous trading day is 0.0807%.
What is the most recent average sentiment score for BIOLIFE SOLUTIONS INC (BLFS:NASDAQ)?
The most recent average sentiment score for BIOLIFE SOLUTIONS INC (BLFS:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for BIOLIFE SOLUTIONS INC (BLFS:NASDAQ)?
The most recent sentiment for BIOLIFE SOLUTIONS INC (BLFS:NASDAQ) is .
SEC-8K** Filing Available For BIOLIFE SOLUTIONS INC (BLFS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.